Results 11 to 20 of about 5,097,580 (172)
Current status of the treatment of degenerative mitral valve regurgitation
Revista Portuguesa de Cardiologia, 2021 Degenerative mitral valve disease (myxomatous degeneration or fibroelastic deficiency) is the most common indication for surgical referral to treat mitral regurgitation.
Gonçalo F. Coutinho, Manuel J. Antunes
doaj +2 more sources
Mechanisms of mitral valve development and disease
Frontiers in Cardiovascular MedicineThe mitral valve apparatus comprises the annulus, valve leaflets, chordae tendineae, and papillary muscles, forming an integrated biomechanical unit essential for unidirectional blood flow.
Enshi Wang, Bin Zhou, Bin Zhou
doaj +2 more sources
Echo Research and Practice, 2020 Mitral valve repair is the gold standard treatment for degenerative mitral valve disease with superior perioperative and long-term morbidity and mortality outcomes vs mitral valve replacement.
Patrick Savage, Michael Connolly
doaj +1 more source
International Journal of Cardiology: Heart & Vasculature, 2020 Objective: The aim of this study is to evaluate mitral valve hemodynamics after mitral valve repair for degenerative disease, and seek the impact of type/size of annuloplasty prosthesis on resting cardiac hemodynamics.
Arudo Hiraoka +6 more
doaj +1 more source
Longitudinal Outcomes Following Surgical Repair of Primary Mitral Regurgitation
Journal of Cardiovascular Development and Disease, 2023 Degenerative mitral valve (MV) disease is the most common cause of organic mitral regurgitation (MR) in developed countries. Surgical mitral valve repair is the gold standard treatment for primary MR.
Yuan Qiu +6 more
doaj +1 more source
Minimally invasive mitral valve repair for degenerative etiology: a comparative study
The Cardiothoracic Surgeon, 2021 Background There is a paucity of data comparing the minimally invasive mitral valve repair (MiMVr) to the conventional approach in patients with degenerative disease.
Mohamed Abdel Hafez Fouly +1 more
doaj +1 more source
Transcatheter heart valve interventions for patients with rheumatic heart disease
Frontiers in Cardiovascular Medicine, 2023 Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the world, outstripping degenerative aortic stenosis numbers fourfold.
Hellmuth Weich +3 more
doaj +1 more source
Percutaneous dual-valve intervention in a high-risk patient with severe aortic and mitral stenosis
Heart Views, 2016 Aortic stenosis is the most frequent and mitral stenosis is the least frequent native single-sided valve disease in Europe. Patients with the combination of severe symptomatic degenerative aortic and mitral stenosis are very rare.
Blaz Mrevlje +2 more
doaj +1 more source
A case control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis [PDF]
, 1997 Objective To investigate the relation of hyperlipidaemia to calcific aortic valve stenosis. Design A case-control study designed to detect a clinically relevant difference in the fasting plasma concentrations of total cholesterol between the groups at ...
Stevenson, R N +3 more
core +1 more source
Инновационная медицина Кубани, 2023 Objective: To compare the outcomes of mitral valve annuloplasty with support rings and that of the current technique employing an autopericardial strip in patients with degenerative diseases (patent RU2774033C1, June 14, 2022).Materials and methods: The ...
K. M. Aminov +5 more
doaj +1 more source